Monday, November 9, 2026

USD/EUR Bullish By 1% In The Last 10 Sessions

ViaNews Editorial Team

February 6, 2023

USD/EUR Bullish By 1% In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.34% for the last 10 sessions. At 17:09 EST on Monday, 6 February, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 7.115% up from its 52-week low and 11.095% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.15%, a negative 0.09%, and a positive 0.52%, respectively.

USD/EUR's highest amplitude of average volatility was 0.19% (last week), 0.42% (last month), and 0.52% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy price analysis: renews three-week high but 50-dma probes bulls. According to FXStreet on Monday, 6 February, "Overall, USD/JPY is likely to extend the latest recovery but a clear upside break of the 50-DMA becomes necessary for the buyer's welcome.", "Following that, an ascending trend line from mid-January will challenge the USD/JPY sellers around 128.20."
  • Usd/jpy price analysis: bulls move in and target 133.00 ahead of the 200-dma. According to FXStreet on Monday, 6 February, "The USD/JPY shifted neutral biased after gapping up from around 131.20 to current exchange rates. ", "A breach of the latter and the USD/JPY could test the day's low at 131.51, followed by last Friday's high at 131.20. "
  • Usd/jpy: the ingredients are in place for a renewed move lower – HSBC. According to FXStreet on Monday, 6 February, "A move lower in USD/JPY over the coming few weeks will mostly rely on the outlook for BoJ policy change, but other more medium-term forces (such as improving current account balance) should also be helping in the background."
  • Usd/jpy eases from multi-week top, bullish potential intact amid post-nfp USD strength. According to FXStreet on Monday, 6 February, "The prevalent risk-off environment - as depicted by a generally weaker tone around the equity markets - underpins the safe-haven Japanese Yen (JPY) and acts as a headwind for the USD/JPY pair. ", "The USD/JPY pair struggles to capitalize on its modest bullish gap opening and retreats a few pips from over a three-week high touched earlier this Monday. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com